Invesco Global Listed Private Equity ETF (PSP)
| Assets | $244.71M |
| Expense Ratio | 1.80% |
| PE Ratio | 15.57 |
| Shares Out | 3.89M |
| Dividend (ttm) | $3.57 |
| Dividend Yield | 5.68% |
| Ex-Dividend Date | Jun 22, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | 88.47% |
| Volume | 29,749 |
| Open | 63.54 |
| Previous Close | 63.71 |
| Day's Range | 62.89 - 63.54 |
| 52-Week Low | 54.12 |
| 52-Week High | 72.90 |
| Beta | 1.25 |
| Holdings | 74 |
| Inception Date | Oct 24, 2006 |
About PSP
Fund Home PageThe Invesco Global Listed Private Equity ETF (PSP) is an exchange-traded fund that mostly invests in financials equity. The fund tracks a modified market-cap weighted index of publicly listed private equity firms. PSP was launched on Oct 24, 2006 and is issued by Invesco.
Top 10 Holdings
49.14% of assets| Name | Symbol | Weight |
|---|---|---|
| 3i Group plc | III | 5.67% |
| TPG Inc. | TPG | 5.63% |
| Blackstone Inc. | BX | 5.45% |
| KKR & Co. Inc. | KKR | 5.20% |
| EQT AB (publ) | EQT | 4.92% |
| Blue Owl Capital Inc. | OWL | 4.87% |
| CVC Capital Partners plc | CVC | 4.52% |
| Sofina Société Anonyme | SOF | 4.34% |
| HAL Trust | HAL | 4.32% |
| Partners Group Holding AG | PGHN | 4.22% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 22, 2026 | $1.11177 | Jun 26, 2026 |
| Mar 23, 2026 | $0.15286 | Mar 27, 2026 |
| Dec 22, 2025 | $1.47174 | Dec 26, 2025 |
| Sep 22, 2025 | $0.83642 | Sep 26, 2025 |
| Jun 23, 2025 | $1.4049 | Jun 27, 2025 |
| Mar 24, 2025 | $0.22234 | Mar 28, 2025 |
Performance
PSP had a total return of -6.35% in the past year, including dividends. Since the fund's inception, the average annual return has been 2.75%.
News
Risk-Wary Family Offices Double Down on Infrastructure
Geopolitical shocks have pushed family offices to rethink nearly every corner of their portfolios. Infrastructure has emerged as the asset class they trust most right now.
Alzprotect Announces FDA Clearance of IND for AZP2006 (Ezeprogind®) in Progressive Supranuclear Palsy (PSP)
LILLE, France--(BUSINESS WIRE)-- #PSP--Alzprotect today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for AZP2006 (Eze...
Collect 12% Yields By Investing Like A Billionaire In 2025
If you've been investing for a while, you've probably thought about private equity more than once. Adding exposure to “PE” firms, which buy and sell privately held businesses, is a great way to divers...
FDA Clears Abionic's IVD CAPSULE PSP for the Early Detection of Sepsis
EPALINGES, Switzerland--(BUSINESS WIRE)--Abionic, an emerging medical diagnostics company focused on rapid early detection technologies, announced today that its IVD CAPSULE PSP test has received 510(...